Britannia Life Sciences Statistics
Total Valuation
CSE:BLAB has a market cap or net worth of CAD 16.23 million. The enterprise value is 17.81 million.
| Market Cap | 16.23M |
| Enterprise Value | 17.81M |
Important Dates
The last earnings date was Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:BLAB has 162.25 million shares outstanding.
| Current Share Class | 162.25M |
| Shares Outstanding | 162.25M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 37.21% |
| Owned by Institutions (%) | n/a |
| Float | 101.88M |
Valuation Ratios
The trailing PE ratio is 2.10.
| PE Ratio | 2.10 |
| Forward PE | n/a |
| PS Ratio | -16.21 |
| PB Ratio | 0.94 |
| P/TBV Ratio | 0.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.87 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.35 |
Financial Position
The company has a current ratio of 3.55, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.55 |
| Quick Ratio | 3.44 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.06 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 66.01% and return on invested capital (ROIC) is -50.86%.
| Return on Equity (ROE) | 66.01% |
| Return on Assets (ROA) | -7.16% |
| Return on Invested Capital (ROIC) | -50.86% |
| Return on Capital Employed (ROCE) | -14.67% |
| Weighted Average Cost of Capital (WACC) | 3.56% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 28 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CSE:BLAB has paid 1.61 million in taxes.
| Income Tax | 1.61M |
| Effective Tax Rate | 17.48% |
Stock Price Statistics
The stock price has increased by +42.86% in the last 52 weeks. The beta is -0.12, so CSE:BLAB's price volatility has been lower than the market average.
| Beta (5Y) | -0.12 |
| 52-Week Price Change | +42.86% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.08 |
| Relative Strength Index (RSI) | 59.31 |
| Average Volume (20 Days) | 171,226 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:BLAB had revenue of CAD -1.00 million and earned 20.49 million in profits. Earnings per share was 0.13.
| Revenue | -1.00M |
| Gross Profit | -726,721 |
| Operating Income | -2.53M |
| Pretax Income | 9.23M |
| Net Income | 20.49M |
| EBITDA | -2.44M |
| EBIT | -2.53M |
| Earnings Per Share (EPS) | 0.13 |
Balance Sheet
The company has 15.89 million in cash and 248,559 in debt, giving a net cash position of 15.64 million or 0.10 per share.
| Cash & Cash Equivalents | 15.89M |
| Total Debt | 248,559 |
| Net Cash | 15.64M |
| Net Cash Per Share | 0.10 |
| Equity (Book Value) | 17.23M |
| Book Value Per Share | 0.11 |
| Working Capital | 12.19M |
Cash Flow
In the last 12 months, operating cash flow was -4.10 million and capital expenditures 12,628, giving a free cash flow of -4.09 million.
| Operating Cash Flow | -4.10M |
| Capital Expenditures | 12,628 |
| Free Cash Flow | -4.09M |
| FCF Per Share | -0.03 |
Margins
| Gross Margin | n/a |
| Operating Margin | 253.16% |
| Pretax Margin | -921.54% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:BLAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 126.27% |
| FCF Yield | -25.20% |
Stock Splits
The last stock split was on November 18, 2021. It was a reverse split with a ratio of 0.1.
| Last Split Date | Nov 18, 2021 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |